证券代码：000615 证券简称：*ST美谷 公告编号：2025-084 奥园美谷科技股份有限公司 关于重大诉讼进展的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 特别提示： 1、案件所处的诉讼阶段：执行； 2、上市公司所处的当事人地位：被告（担保方）； 根据上述《民事调解书》的相关约定，金环绿纤应于 2025 年 3 月 7 日前偿 还债务金额约 21,203.12 万元（具体金额最终以银行系统计算为准），金环绿纤 出现未能如期偿还前述债务的情形。具体详见公司于 2025 年 3 月 8 日在巨潮资 讯网披露的《关于控股子公司债务逾期的进展公告》。 公司于 2025 年 3 月 14 日收到襄阳中院送达的编号（2025）鄂 06 执 27 号《执 行通知书》，主要内容为"被执行人湖北金环绿色纤维有限公司偿还申请执行人 中国银行股份有限公司襄阳分行本金 187,507,905.75 元，支付截止 2025 年 3 月 7 日利息、罚息和复利等 2,714 万元；支付以本金 187,507,905.75 元为基数 至借款还清之日止的利息、罚息和复利等(以 ...

Group 1 - The medical beauty sector experienced a decline of 0.22% on October 27, with *ST Meigu leading the drop [1] - The Shanghai Composite Index closed at 3996.94, up 1.18%, while the Shenzhen Component Index closed at 13489.4, up 1.51% [1] - Key stocks in the medical beauty sector showed varied performance, with Huaxi Biological up 0.59% and *ST Meigu down 2.70% [1] Group 2 - The net outflow of main funds in the medical beauty sector was 5.59 million yuan, while retail funds saw a net outflow of 4.18 million yuan [1] - The table of fund flows indicates that Aimei Ke had a main fund inflow of 3.96 million yuan but a retail outflow of 15.46 million yuan [2] - *ST Meigu had a significant main fund outflow of 9.57 million yuan, indicating a negative sentiment among institutional investors [2]

Group 1 - The medical beauty sector experienced a decline of 0.12% on October 23, with Jinbo Biological leading the drop [1] - The Shanghai Composite Index closed at 3922.41, up 0.22%, while the Shenzhen Component Index closed at 13025.45, also up 0.22% [1] - Key stocks in the medical beauty sector showed mixed performance, with Aimeike rising by 0.64% and Jinbo Biological falling by 2.84% [1] Group 2 - The net outflow of main funds in the medical beauty sector was 32.09 million yuan, while retail funds saw a net inflow of 10.22 million yuan [1] - Specific stock fund flows indicated that *ST Meigu experienced a main fund outflow of 6.29 million yuan, while retail funds had a net inflow of 6.18 million yuan [2] - Huaxi Biological also faced a main fund outflow of 10.03 million yuan, with retail funds showing a net inflow of 4.67 million yuan [2]

Core Insights - The medical beauty sector experienced a slight decline of 0.17% on October 22, with Ai Meike leading the drop [1] - The Shanghai Composite Index closed at 3913.76, down 0.07%, while the Shenzhen Component Index closed at 12996.61, down 0.62% [1] Sector Performance - The closing prices and performance of key stocks in the medical beauty sector are as follows: - *ST Meigu: Closed at 3.69, up 4.53% with a trading volume of 293,600 shares and a transaction value of 108 million yuan [1] - Huaxi Biological: Closed at 53.70, up 0.45% with a trading volume of 20,500 shares and a transaction value of 1.1017 million yuan [1] - Jinbo Biological: Closed at 262.87, down 0.38% with a trading volume of 6,168 shares and a transaction value of 163 million yuan [1] - Ai Meike: Closed at 166.15, down 0.98% with a trading volume of 17,500 shares and a transaction value of 292 million yuan [1] Capital Flow - The medical beauty sector saw a net outflow of 20.9685 million yuan from main funds, while retail investors contributed a net inflow of 11.5985 million yuan [1] - Detailed capital flow for key stocks: - Huaxi Biological: Main funds net inflow of 10.7629 million yuan (9.81% of total), retail net outflow of 8.6171 million yuan (-7.86% of total) [2] - *ST Meigu: Main funds net inflow of 719,200 yuan (0.66% of total), retail net outflow of 2.7039 million yuan (-2.49% of total) [2] - Ai Meike: Main funds net outflow of 32.4506 million yuan (-11.11% of total), retail net inflow of 22.9195 million yuan (7.84% of total) [2]

Group 1 - The company has a significant portion of its revenue coming from overseas business, indicating a strong international presence [2] - The company's subsidiary, Hubei Jinhui New Materials Technology Co., Ltd., is one of the main producers of viscose filament yarn in China, with sales extending to countries such as South Korea, India, Pakistan, Vietnam, and Turkey [2]

Group 1 - The medical beauty sector increased by 0.63% on October 21, with Jinbo Biological leading the gains [1] - The Shanghai Composite Index closed at 3916.33, up 1.36%, while the Shenzhen Component Index closed at 13077.32, up 2.06% [1] - Key stocks in the medical beauty sector showed varied performance, with Jinbo Biological closing at 263.87, up 1.10%, and Aimeike at 167.80, up 0.46% [1] Group 2 - The medical beauty sector experienced a net outflow of 127.96 thousand yuan from main funds and 928.94 thousand yuan from speculative funds, while retail investors saw a net inflow of 1,056.9 thousand yuan [1] - Aimeike had a main fund net inflow of 503.62 thousand yuan, but a net outflow of 971.83 thousand yuan from speculative funds [2] - Huaxi Biological faced a net outflow of 291.25 thousand yuan from main funds and 55.17 thousand yuan from speculative funds, with a net inflow of 346.42 thousand yuan from retail investors [2]

Group 1 - The medical beauty sector experienced a decline of 0.94% on October 20, with Jinbo Biological leading the drop [1] - The Shanghai Composite Index closed at 3863.89, up 0.63%, while the Shenzhen Component Index closed at 12813.21, up 0.98% [1] - Major stocks in the medical beauty sector showed mixed performance, with *ST Meigu closing at 3.51, up 1.45%, and Jinbo Biological at 261.00, down 3.45% [1] Group 2 - The net outflow of main funds in the medical beauty sector was 41.23 million yuan, while retail investors saw a net inflow of 57.45 million yuan [1] - Specific stock fund flows indicated that *ST Meigu had a net inflow of 0.75%, while Huaxi Biological and Aimeike experienced net outflows of 8.64% and 6.24%, respectively [2]

Core Viewpoint - The medical beauty sector experienced a decline of 2.52% on October 17, with Jinbo Biological leading the drop. The Shanghai Composite Index closed at 3839.76, down 1.95%, while the Shenzhen Component Index closed at 12688.94, down 3.04% [1]. Group 1: Market Performance - The medical beauty sector saw a net outflow of main funds amounting to 84.94 million yuan, while retail investors had a net inflow of 95.23 million yuan [1]. - Individual stocks in the medical beauty sector showed varied performance, with *ST Meigu closing at 3.46 yuan, up 0.29%, and Jinbo Biological closing at 270.32 yuan, down 3.86% [1]. Group 2: Fund Flow Analysis - Main funds for *ST Meigu recorded a net outflow of 8.72 million yuan, while retail investors had a net inflow of 4.88 million yuan [2]. - For Huaxi Biological, main funds experienced a net outflow of 9.24 million yuan, with retail investors seeing a net inflow of 9.06 million yuan [2]. - Aimeike faced a significant net outflow of 66.98 million yuan from main funds, while retail investors had a net inflow of 81.30 million yuan [2].

New Stock Issuance - New stock issuance includes 泰凯英 (code: 920020) at an issuance price of 7.50 and 超颖电子 (code: 732175) at 17.08[1] Equity Market Alerts - 上纬新材 (code: 688585) is undergoing a tender offer from September 29, 2025, to October 28, 2025[1] - 科思科技 (code: 688788) and 博瑞医药 (code: 688166) have recent announcements dated September 26, 2025, and October 10, 2025, respectively[1] - 南新制药 (code: 688189) reported severe abnormal fluctuations on October 10, 2025[1] Trading Alerts - A total of 50 stocks have trading alerts with the latest announcements on October 15, 2025, including 国光连锁 (code: 605188) and 中持股份 (code: 603903)[1] - The lowest trading alert price recorded is 1,116 for 赛恩斯 (code: 688480)[1]

Core Insights - The medical beauty sector experienced a slight increase of 0.28% on October 15, with Jinbo Biological leading the gains [1] - The Shanghai Composite Index closed at 3912.21, up 1.22%, while the Shenzhen Component Index closed at 13118.75, up 1.73% [1] Medical Beauty Sector Performance - Jinbo Biological (code: 920982) closed at 290.43, with a rise of 5.00% and a trading volume of 21,800 shares, totaling a transaction value of 628 million [1] - Huaxi Biological (code: 688363) closed at 54.72, up 1.30%, with a trading volume of 23,600 shares and a transaction value of 129 million [1] - Aimeike (code: 300896) closed at 175.15, down 0.19%, with a trading volume of 23,500 shares and a transaction value of 412 million [1] - *ST Meigu (code: 000615) closed at 3.52, down 3.03%, with a trading volume of 199,800 shares and a transaction value of 71.2 million [1] Fund Flow Analysis - The medical beauty sector saw a net outflow of 21.57 million from institutional investors and 5.26 million from retail investors, while individual investors contributed a net inflow of 26.84 million [1] - Huaxi Biological had a net inflow of 2.29 million from institutional investors, while it faced a net outflow of 5.18 million from retail investors [2] - *ST Meigu experienced a significant net outflow of 9.34 million from institutional investors, despite a net inflow of 4.25 million from retail investors [2] - Aimeike faced a net outflow of 14.53 million from institutional investors, while retail investors contributed a net inflow of 19.70 million [2]